Elicera Therapeutics (ELIC) Investor Update summary

Digital investor meeting

• CEO Jamal El-Mosleh to present and answer investor questions online via Microsoft Teams on March 4, 2025, at 16:00, in connection with TO2 warrant exercise.

• Registration by email was requested by 15:00 on February 28, 2025.

Life Science Day

• Jamal El-Mosleh to present at Life Science Day in Gothenburg on March 5, 2025, at 09:45; the presentation can be viewed live online.

• In-person attendance is at Wallenberg Conference Centre, Sahlgrenska Academy, and requires registration through the event website.

Pipeline and platform

• Four drug candidates in development: two CAR T-cell therapies and two oncolytic viruses, based on research from Professor Magnus Essand’s group at Uppsala University.

• iTANK is a commercially available platform designed to enhance CAR T-cell effects and activate killer T cells against cancer; it is also offered for licensing to CAR T developers.